Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangioles
- 1 October 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (4) , 1238-1251
- https://doi.org/10.1053/gast.2002.35948
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitisGastrointestinal Endoscopy, 2001
- Ursodiol for Primary Sclerosing CholangitisNew England Journal of Medicine, 1997
- Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitisJournal of Hepatology, 1997
- The role of bile salt composition in liver pathology of mdr2 (−/−) mice: differences between males and femalesJournal of Hepatology, 1997
- Linomide prevents the lethal effect of anti-Fas antibody and reduces Fas-mediated ceramide production in mouse hepatocytes.Journal of Clinical Investigation, 1996
- Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.Journal of Clinical Investigation, 1995
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseasePublished by Elsevier ,1993
- Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated ratDigestive Diseases and Sciences, 1993
- Ursodeoxycholate has no beneficial effect on liver function or histology in biliary cirrhosis in the ratJournal of Hepatology, 1992
- A randomized clinical trial of oral ursodeoxycholic acid in obstructive jaundiceBritish Journal of Surgery, 1986